TGFB1 antibody (AA 279-390)
Quick Overview for TGFB1 antibody (AA 279-390) (ABIN7628699)
Target
See all TGFB1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 279-390
-
Purpose
- Transforming Growth Factor Beta 1 (TGFb1) Monoclonal Antibody
-
Sequence
- Ala279~Ser390
-
Characteristics
- The Transforming Growth Factor Beta 1 (TGFb1) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Protein A + Protein G affinity chromatography
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Alternative Name
- TGFb1
-
Gene ID
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Target
-